Natural History of Infants With Patent Processus Vaginalis
Launched by CHILDREN'S MERCY HOSPITAL KANSAS CITY · Feb 1, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying infants with a condition called Patent Processus Vaginalis (PPV), which can lead to inguinal hernias. Researchers want to understand how often and when these hernias occur in children who have undergone a specific type of surgery for another condition called pyloric stenosis. The study will follow participants from the time of their surgery until they are almost 18 years old, using annual phone calls or emails to check in on their health.
To be eligible for this trial, participants need to be infants under four months old who are having laparoscopic surgery for pyloric stenosis. However, those with certain conditions, like undescended testes or specific abdominal issues, cannot participate. If you choose to join, you will help contribute valuable information that could improve understanding and treatment of PPV and inguinal hernias in the future. The trial is currently recruiting participants and will continue until July 2025.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients having laparoscopic surgery for pyloric stenosis. Subjects are anticipated to be less than four months of age at the time of enrollment.
- • Enrollment inclusion dates: 08/2016 (upon IRB approval) to 7/31/2025
- Exclusion Criteria:
- • Patients who are anticipated to have a hostile abdomen for visualizing the inguinal rings (e.g. gastroschisis, necrotizing enterocolitis)
- • Patients who have unilateral or bilateral undescended testes
- • Patients undergoing open pyloromyotomy
- • Patients who have a known hernia
About Children's Mercy Hospital Kansas City
Children's Mercy Hospital Kansas City is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical trials. As a leading sponsor of clinical trials, the hospital focuses on developing and testing new treatments and therapies that address a wide range of pediatric conditions. With a commitment to excellence in patient care and a collaborative approach to research, Children's Mercy is at the forefront of pediatric medicine, striving to improve outcomes and enhance the quality of life for children and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Patients applied
Trial Officials
Shawn D St. Peter, MD
Principal Investigator
Children's Mercy Hospital Kansas City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials